Karyopharm Therapeutics Inc. (KPTI) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Karyopharm Therapeutics I...

    NASDAQ: KPTI · Real-Time Price · USD
    6.33
    0.08 (1.28%)
    At close: Sep 09, 2025, 3:59 PM
    6.64
    4.90%
    Pre-market: Sep 10, 2025, 08:45 AM EDT

    Karyopharm Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -76.42M -143.1M -165.29M -124.09M
    Depreciation & Amortization
    		 340K 530K 621K 789K
    Stock-Based Compensation
    		 18.43M 21.71M 35.4M 29.78M
    Other Working Capital
    		 3.21M 9.76M -15.96M -9.26M
    Other Non-Cash Items
    		 -69.53M -3.28M -294K 8.13M
    Deferred Income Tax
    		 n/a n/a n/a 1.45M
    Change in Working Capital
    		 -302K 31.41M -19.99M -23.19M
    Operating Cash Flow
    		 -127.49M -92.72M -149.55M -107.12M
    Capital Expenditures
    		 -142K n/a -118K -5.71M
    Cash Acquisitions
    		 n/a n/a 104.26M 5.5M
    Purchase of Investments
    		 -58.82M -159.15M -226.02M -45.23M
    Sales Maturities Of Investments
    		 154.44M 167.09M 121.88M 192.78M
    Other Investing Acitivies
    		 n/a n/a -104.26M -5.5M
    Investing Cash Flow
    		 95.47M 7.94M -104.26M 141.84M
    Debt Repayment
    		 83.3M n/a n/a 60M
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 -43.11M n/a 3.98M 3.75M
    Financial Cash Flow
    		 41.65M 1.12M 193.74M 73.65M
    Net Cash Flow
    		 9.62M -83.69M -60.56M 108.32M
    Free Cash Flow
    		 -127.63M -92.72M -149.67M -112.83M

    Add to Watchlist